Clinical Trials

Insights into the quest to find an effective treatment for this socially painful condition

Substandard and falsified medicines are a global threat, but a collective pushback can beat them

Is now finally the time for Alzheimer’s drug development to shine?

In 2014, the Ice Bucket Challenge raised millions; eight years on, we have an FDA-approved therapy

AI’s role in pharma operations and process is growing. But does it have the power to transform the industry?

How two rival projects relate to a modern disease landscape threatened by climate change and low vaccination rates

What role must pharma play to help improve outcomes for women?

The cell cycle can be used to shut down cancer’s survival mechanisms, but what does it take to turn that knowledge into a medicine?

Two friends, two countries; one disease, one network to fight it. We spoke to two leaders of DNDi’s Leishmaniasis East Africa Network.

Clinical trials? Cancer R&D? AstraZeneca’s Matthew Ellis shares his views on the future of pharma.